<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html><head><meta content="text/html; charset=ISO-8859-1" http-equiv="content-type"><title>horny goat weed abstract alement overview</title></head><body>
<p data-path-to-node="0">Based on clinical data and preclinical pharmacological research retrieved from the provided sources, the efficacy of <i data-path-to-node="0" data-index-in-node="117">Epimedium</i> (Horny Goat Weed) across various ailments is sorted below.</p>
<h3 data-path-to-node="1"><b data-path-to-node="1" data-index-in-node="0">Ailments with Demonstrated Efficacy (Clinical Evidence)</b></h3>
<p data-path-to-node="2">Sorted by the robustness of reported clinical outcomes and effective rates:</p>
<ol start="1" data-path-to-node="3">
<li><p data-path-to-node="3,0,0"><b data-path-to-node="3,0,0" data-index-in-node="0">Periodontitis (Co-occurring with Osteoporosis):</b> In a retrospective clinical study, <i data-path-to-node="3,0,0" data-index-in-node="83">Epimedium</i> flavonoid treatment achieved a <b data-path-to-node="3,0,0" data-index-in-node="124">91.7% total effective rate</b>, significantly improving periodontal health metrics and inflammatory markers in gingival fluid.</p></li><li><p data-path-to-node="3,1,0"><b data-path-to-node="3,1,0" data-index-in-node="0">Osteoporosis:</b> Clinical trials demonstrate that <i data-path-to-node="3,1,0" data-index-in-node="47">Epimedium</i>
and its extracts significantly increase bone mineral density (BMD) in
the lumbar spine and proximal femur, with one study reporting a <b data-path-to-node="3,1,0" data-index-in-node="191">95.0% total effective rate</b> as an adjunctive therapy.</p></li><li><p data-path-to-node="3,2,0"><b data-path-to-node="3,2,0" data-index-in-node="0">Sexual Dysfunction (Erectile Dysfunction):</b> Modern clinical practice and restorative trials show that icariin, the active ingredient in <i data-path-to-node="3,2,0" data-index-in-node="135">Epimedium</i>, is effective in restoring spontaneous erections and repairing penile tissue pathological changes.</p></li><li><p data-path-to-node="3,3,0"><b data-path-to-node="3,3,0" data-index-in-node="0">Thin Endometrium:</b>
Randomized controlled trials (RCTs) have reported successful
application of icariin for increasing endometrial thickness in
infertile women, although systematic reviews are ongoing to confirm
full scale efficacy.</p></li>
</ol>
<h3 data-path-to-node="4"><b data-path-to-node="4" data-index-in-node="0">Ailments with Greatest Theoretical Efficacy (Preclinical/Animal Models)</b></h3>
<p data-path-to-node="5">Sorted by the magnitude of effect observed in laboratory and animal simulations:</p>
<ol start="1" data-path-to-node="6">
<li><p data-path-to-node="6,0,0"><b data-path-to-node="6,0,0" data-index-in-node="0">Hepatocellular Carcinoma (Liver Cancer):</b>
Theoretical synergy between icaritin and autophagy inhibitors shows
high efficacy in inducing cancer cell death through
PINK1/Parkin-mediated mitophagy.</p></li><li><p data-path-to-node="6,1,0"><b data-path-to-node="6,1,0" data-index-in-node="0">Ischemic Stroke:</b> In rat models, icariin reduced cortical infarct volume by <b data-path-to-node="6,1,0" data-index-in-node="75">32% to 40%</b>
and significantly improved neurological function scores by inhibiting
mitochondrial permeability transition pore (mPTP) opening.</p></li><li><p data-path-to-node="6,2,0"><b data-path-to-node="6,2,0" data-index-in-node="0">Colorectal Cancer:</b> <i data-path-to-node="6,2,0" data-index-in-node="19">Epimedium</i>
is theorized to have significant effects when combined with PD-1
inhibitors, as it promotes ferroptosis and activates CD8(+) T cells to
secrete IFN-&#947;, enhancing immunotherapy response.</p></li><li><p data-path-to-node="6,3,0"><b data-path-to-node="6,3,0" data-index-in-node="0">Inflammatory Diseases (Rheumatoid Arthritis &amp; Ulcerative Colitis):</b>
High efficacy is predicted for targeted delivery systems (such as
exosome-loaded icariin), which have shown marked symptom mitigation,
colon lengthening, and M1-to-M2 macrophage phenotypic transitions in
animal models.</p></li><li><p data-path-to-node="6,4,0"><b data-path-to-node="6,4,0" data-index-in-node="0">COVID-19:</b>
Research hypothesizes a strong potential for icariin to inhibit
SARS-CoV-2 entry into host cells by modulating specific intracellular
pathways.</p></li><li><p data-path-to-node="6,5,0"><b data-path-to-node="6,5,0" data-index-in-node="0">Depression:</b>
Network pharmacology and molecular docking technologies predict
multi-target mechanisms involving IL6 and AKT1, suggesting a high
theoretical capacity for treating depressive symptoms.</p></li>
</ol>
<p data-path-to-node="7">The model size for Gemini 1.5 Pro is not
publicly disclosed by Google; however, it is estimated to have
approximately 1.5 trillion parameters, which typically corresponds to a
storage size of approximately <b data-path-to-node="7" data-index-in-node="206">600 GB to 800 GB</b> in non-quantized form. [This has source</p>
<p data-path-to-node="7"><br>
</p>
<h1 data-path-to-node="0">Report: Efficacy Sorting of <i data-path-to-node="0" data-index-in-node="28">Epimedium</i> (Horny Goat Weed) Applications</h1>
<p data-path-to-node="1">Based on clinical data and preclinical pharmacological research retrieved from relevant studies, the efficacy of <i data-path-to-node="1" data-index-in-node="113">Epimedium</i> across various ailments is categorized and sorted below.</p>
<h3 data-path-to-node="2"><b data-path-to-node="2" data-index-in-node="0">Ailments with Demonstrated Efficacy (Clinical Evidence)</b></h3>
<p data-path-to-node="3">Sorted by the robustness of reported clinical outcomes and effective rates:</p>
<ol start="1" data-path-to-node="4">
<li><p data-path-to-node="4,0,0"><b data-path-to-node="4,0,0" data-index-in-node="0">Guo,
Y., Ge, X., Wang, W., Wang, R., Chen, Q., &amp; Wang, H. (2024).
"Epimedium applied in the clinical treatment of osteoporosis patients
with periodontitis."</b></p><ul data-path-to-node="4,0,1"><li><p data-path-to-node="4,0,1,0,0"><b data-path-to-node="4,0,1,0,0" data-index-in-node="0">Periodontitis (Co-occurring with Osteoporosis):</b> In a retrospective clinical study, <i data-path-to-node="4,0,1,0,0" data-index-in-node="83">Epimedium</i> flavonoid treatment achieved a <b data-path-to-node="4,0,1,0,0" data-index-in-node="124">91.7% total effective rate</b>, significantly improving periodontal health metrics and inflammatory markers in gingival fluid.</p></li></ul></li><li><p data-path-to-node="4,1,0"><b data-path-to-node="4,1,0" data-index-in-node="0">Guo,
Y., Ge, X., Wang, W., Wang, R., Chen, Q., &amp; Wang, H. (2024).
"Epimedium applied in the clinical treatment of osteoporosis patients
with periodontitis."</b></p><ul data-path-to-node="4,1,1"><li><p data-path-to-node="4,1,1,0,0"><b data-path-to-node="4,1,1,0,0" data-index-in-node="0">Osteoporosis:</b> Clinical trials demonstrate that <i data-path-to-node="4,1,1,0,0" data-index-in-node="47">Epimedium</i>
and its extracts significantly increase bone mineral density (BMD) in
the lumbar spine and proximal femur, with one study reporting a <b data-path-to-node="4,1,1,0,0" data-index-in-node="191">95.0% total effective rate</b> as an adjunctive therapy.</p></li></ul></li><li><p data-path-to-node="4,2,0"><b data-path-to-node="4,2,0" data-index-in-node="0">Chen,
X. L., Li, S. X., Ge, T., Zhang, D. D., Wang, H. F., Wang, W., Li, Y.
Z., &amp; Song, X. M. (2024). "Epimedium Linn: A Comprehensive Review
of Phytochemistry, Pharmacology, Clinical Applications and Quality
Control."</b></p><ul data-path-to-node="4,2,1"><li><p data-path-to-node="4,2,1,0,0"><b data-path-to-node="4,2,1,0,0" data-index-in-node="0">Sexual Dysfunction (Erectile Dysfunction):</b> Modern clinical practice and restorative trials show that icariin, the active ingredient in <i data-path-to-node="4,2,1,0,0" data-index-in-node="135">Epimedium</i>, is effective in restoring spontaneous erections and repairing penile tissue pathological changes.</p></li></ul></li><li><p data-path-to-node="4,3,0"><b data-path-to-node="4,3,0" data-index-in-node="0">Chen,
X. L., Li, S. X., Ge, T., Zhang, D. D., Wang, H. F., Wang, W., Li, Y.
Z., &amp; Song, X. M. (2024). "Epimedium Linn: A Comprehensive Review
of Phytochemistry, Pharmacology, Clinical Applications and Quality
Control."</b></p><ul data-path-to-node="4,3,1"><li><p data-path-to-node="4,3,1,0,0"><b data-path-to-node="4,3,1,0,0" data-index-in-node="0">Thin Endometrium:</b>
Randomized controlled trials (RCTs) have reported successful
application of icariin for increasing endometrial thickness in
infertile women, although systematic reviews are ongoing to confirm
full scale efficacy.</p></li></ul></li>
</ol>
<hr data-path-to-node="5">
<h3 data-path-to-node="6"><b data-path-to-node="6" data-index-in-node="0">Ailments with Greatest Theoretical Efficacy (Preclinical/Animal Models)</b></h3>
<p data-path-to-node="7">Sorted by the magnitude of effect observed in laboratory and animal simulations:</p>
<ol start="1" data-path-to-node="8">
<li><p data-path-to-node="8,0,0"><b data-path-to-node="8,0,0" data-index-in-node="0">Luo,
P., An, Y., He, J., Xing, X., Zhang, Q., Liu, X., Chen, Y., Yuan, H.,
Chen, J., Wong, Y. K., Huang, J., Gong, Z., Du, Q., Xiao, W., &amp;
Wang, J. (2024). "Icaritin with autophagy/mitophagy inhibitors
synergistically enhances anticancer efficacy and apoptotic effects
through PINK1/Parkin-mediated mitophagy in hepatocellular carcinoma."</b></p><ul data-path-to-node="8,0,1"><li><p data-path-to-node="8,0,1,0,0"><b data-path-to-node="8,0,1,0,0" data-index-in-node="0">Hepatocellular Carcinoma (Liver Cancer):</b>
Theoretical synergy between icaritin and autophagy inhibitors shows
high efficacy in inducing cancer cell death through
PINK1/Parkin-mediated mitophagy.</p></li></ul></li><li><p data-path-to-node="8,1,0"><b data-path-to-node="8,1,0" data-index-in-node="0">Zhou,
Z., Li, W., Ni, L., Wang, T., Huang, Yan., Yu, Y., Hu, M., Liu, Y.,
Wang, J., Huang, X., &amp; Wang, Y. (2024). "Icariin improves oxidative
stress injury during ischemic stroke via inhibiting mPTP opening."</b></p><ul data-path-to-node="8,1,1"><li><p data-path-to-node="8,1,1,0,0"><b data-path-to-node="8,1,1,0,0" data-index-in-node="0">Ischemic Stroke:</b> In rat models, icariin reduced cortical infarct volume by <b data-path-to-node="8,1,1,0,0" data-index-in-node="75">32% to 40%</b>
and significantly improved neurological function scores by inhibiting
mitochondrial permeability transition pore (mPTP) opening.</p></li></ul></li><li><p data-path-to-node="8,2,0"><b data-path-to-node="8,2,0" data-index-in-node="0">Haoyue,
W., Kexiang, S., Tan Wei, S., Jiamin, G., Luyun, Y., Junkai, W., &amp;
Wanli, D. (2025). "Icariin promoted ferroptosis by activating
mitochondrial dysfunction to inhibit colorectal cancer and
synergistically enhanced the efficacy of PD-1 inhibitors."</b></p><ul data-path-to-node="8,2,1"><li><p data-path-to-node="8,2,1,0,0"><b data-path-to-node="8,2,1,0,0" data-index-in-node="0">Colorectal Cancer:</b> <i data-path-to-node="8,2,1,0,0" data-index-in-node="19">Epimedium</i>
is theorized to have significant effects when combined with PD-1
inhibitors, as it promotes ferroptosis and activates CD8(+) T cells to
secrete IFN-&#947;, enhancing immunotherapy response.</p></li></ul></li><li><p data-path-to-node="8,3,0"><b data-path-to-node="8,3,0" data-index-in-node="0">Yan,
Q., Liu, H., Sun, S., Yang, Y., Fan, D., Yang, Y., Zhao, Y., Song, Z.,
Chen, Y., Zhu, R., &amp; Zhang, Z. (2024). "Adipose-derived stem cell
exosomes loaded with icariin alleviates rheumatoid arthritis by
modulating macrophage polarization in rats." AND Zhao, L., Jiang, T.,
Zhang, Y., &amp; Shen, Z. (2024). "Epimedium polysaccharides ameliorate
ulcerative colitis by inhibiting oxidative stress and regulating
autophagy."</b></p><ul data-path-to-node="8,3,1"><li><p data-path-to-node="8,3,1,0,0"><b data-path-to-node="8,3,1,0,0" data-index-in-node="0">Inflammatory Diseases (Rheumatoid Arthritis &amp; Ulcerative Colitis):</b>
High efficacy is predicted for targeted delivery systems (such as
exosome-loaded icariin), which have shown marked symptom mitigation,
colon lengthening, and M1-to-M2 macrophage phenotypic transitions in
animal models.</p></li></ul></li><li><p data-path-to-node="8,4,0"><b data-path-to-node="8,4,0" data-index-in-node="0">Khezri,
M. R., Nazari-Khanamiri, F., Mohammadi, T., Moloodsouri, D., &amp;
Ghasemnejad-Berenji, M. (2022). "Potential effects of icariin, the
Epimedium-derived bioactive compound in the treatment of COVID-19: a
hypothesis."</b></p><ul data-path-to-node="8,4,1"><li><p data-path-to-node="8,4,1,0,0"><b data-path-to-node="8,4,1,0,0" data-index-in-node="0">COVID-19:</b>
Research hypothesizes a strong potential for icariin to inhibit
SARS-CoV-2 entry into host cells by modulating specific intracellular
pathways.</p></li></ul></li><li><p data-path-to-node="8,5,0"><b data-path-to-node="8,5,0" data-index-in-node="0">Dong,
Y., Tao, B., Xue, X., Feng, C., Ren, Y., Ma, H., Zhang, J., Si, Y.,
Zhang, S., Liu, S., Li, H., Zhou, J., Li, G., Wang, Z., Xie, J., &amp;
Zhu, Z. (2021). "Molecular mechanism of Epicedium treatment for
depression based on network pharmacology and molecular docking
technology."</b></p><ul data-path-to-node="8,5,1"><li><p data-path-to-node="8,5,1,0,0"><b data-path-to-node="8,5,1,0,0" data-index-in-node="0">Depression:</b>
Network pharmacology and molecular docking technologies predict
multi-target mechanisms involving IL6 and AKT1, suggesting a high
theoretical capacity for treating depressive symptoms.</p></li></ul></li>
</ol>
<p data-path-to-node="7">]</p>

  

</body></html>